Related Experiment Video

Updated: Jun 26, 2026

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
07:05

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea

Published on: November 9, 2016

[Observation of botulinum toxin A management in childhood with intermittent exotropia]

Yuan Li1, Xiao Wu

  • 1Beijing Tongren Eye Centre, Affiliated Beijing Tongren Hospital, Capital University of Medical Science, Beijing 100730, China.

[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology
|January 30, 2009
PubMed

Insights

Botulinum toxin A (BTXA) injections offer a less invasive, effective treatment for childhood intermittent exotropia. Both BTXA and surgery showed comparable recovery rates, with BTXA being a rapid outpatient procedure.

Area of Science:

  • Ophthalmology
  • Pediatric Ophthalmology
  • Strabismus Management

Background:

  • Intermittent exotropia is a common childhood strabismus.
  • Current management options include surgery and non-surgical approaches.
  • Evaluating novel treatments like botulinum toxin A is crucial.

Purpose of the Study:

  • To assess the efficacy of botulinum toxin A (BTXA) in managing intermittent exotropia in children.
  • To compare the outcomes of BTXA treatment with traditional surgical recession.

Main Methods:

  • A prospective clinical study involved 60 children (4-12 years) with intermittent exotropia.
  • Patients were assigned to either a surgery group (bilateral rectus muscle recession, n=30) or a BTXA group (bilateral rectus muscle injection, n=30).
  • Eye alignment and binocular vision were evaluated 6 months post-treatment.

Main Results:

  • The BTXA group showed a significant reduction in exodeviation, with a 76.67% recovery rate.
  • The surgery group achieved a 90.00% recovery rate.
  • No statistically significant difference in recovery rates was observed between the BTXA and surgery groups (P=0.166).
  • Improvements in fusion and stereopsis were noted in both groups.

Conclusions:

  • Botulinum toxin A injection is a rapid, less invasive, and effective treatment for childhood intermittent exotropia.
  • BTXA offers a viable alternative to surgery with comparable outcomes.
  • Further research can explore long-term efficacy and optimal dosing for BTXA in strabismus management.
Abstract

Related Concept Videos

Botulism01:22

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
Accessory Structures of the Eye01:17

Accessory Structures of the Eye

Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...